VSR Financial Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-21,787
Closed -$1.52M 601
2015
Q4
$1.52M Sell
21,787
-401
-2% -$28.4K 0.16% 157
2015
Q3
$1.47M Buy
22,188
+95
+0.4% +$7.39K 0.17% 149
2015
Q2
$1.73M Sell
22,093
-194
-0.9% -$15.1K 0.18% 145
2015
Q1
$1.7M Buy
22,287
+81
+0.4% +$5.95K 0.18% 144
2014
Q4
$1.48M Sell
22,206
-504
-2% -$33.6K 0.17% 148
2014
Q3
$1.45M Buy
22,710
+75
+0.3% +$4.63K 0.17% 141
2014
Q2
$1.38M Sell
22,635
-1,203
-5% -$69.7K 0.17% 143
2014
Q1
$1.35M Buy
23,838
+2,129
+10% +$121K 0.19% 135
2013
Q4
$1.16M Buy
21,709
+5,569
+35% +$279K 0.18% 142
2013
Q3
$743K Buy
16,140
+1,292
+9% +$59K 0.13% 181
2013
Q2
$627K Buy
+14,848
New +$618K 0.12% 197

Other funds holding PJP

VSR Financial Services's PJP Position: Q1 2016 in Review

VSR Financial Services sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2016, closing a stake of 21,787 shares — an estimated $1.52M sold.

VSR Financial Services first reported a position in PJP in Q2 2013 and held it in 11 quarters. The position peaked at $1.73M in Q2 2015. 93 funds tracked by Wall St. Rank hold PJP as of Q1 2016.

  • VSR Financial Services reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
  • VSR Financial Services sold 21,787 Invesco Pharmaceuticals ETF shares in Q1 2016, an estimated $1.52M.
  • VSR Financial Services first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 11 quarters.
  • VSR Financial Services's Invesco Pharmaceuticals ETF position peaked at $1.73M in Q2 2015.
  • 93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2016.

Based on VSR Financial Services's 13F filing for Q1 2016, filed 5 May 2016.